US court expedites Indivior rival Dr. Reddy#39;s appeal to re-launch generic drug

US court expedites Indivior rival Dr. Reddy#39;s appeal to re-launch generic drug Indivior won a preliminary injunction earlier this month, preventing India#39;s Dr. Reddy#39;s Laboratories from re-launching its copycat version until the patent litigation is concluded or until the company prevails on an appeal of the injunction.

No comments:

Post a Comment